News

Article

Glaucoma 360 Premier Event: The Annual Gala

Author(s):

The Annual Gala will be held on February 8 from 6 to 9 pm Pacific Standard Time.

(image Credit: AdobeStock/BlackMediaHouse)

(image Credit: AdobeStock/BlackMediaHouse)

The Glaucoma Research Foundation’s Glaucoma 360 Annual Meeting is on the horizon. The event, which spans 3 days and is loaded with numerous educational and networking opportunities covering all aspects of glaucoma diagnosis, treatment, technological updates, and treatments in the industry pipeline, will run from Thursday February 8 to Saturday February 10, 2024, at the Westin St. Francis San Francisco on Union Square, 335 Powell Street, San Francisco.

The highlight of the 3 days is by far the Annual Gala held on February 8 from 6 to 9 pm Pacific Standard Time. This is the principal fundraising event of the year for the Foundation. This year’s theme is Honoring Innovation.

The agenda for the black tie event is as follows:

  • 6:00 pm: President’s Reception
  • 7:00 pm: Dinner, Live Auction, and Awards Presentations
  • 9:00 pm: Innovators Circle Afterparty

The Foundation uses the Gala as an opportunity to celebrate individuals who have contributed substantially to eradicating glaucoma.

This year the Catalyst Award will honor recipients Judy and Charles Munnerlyn, philanthropists and laser vision pioneers.

The Visionary Award will go to the Zander Family, philanthropists and glaucoma advocates.

The President's Award recipient will be Patricia Caulfield, a visually impaired artist, patient advocate, and community leader.

Individuals interested in attending the Gala can register online.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.